age-related maculopathy


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.

maculopathy, age-related

A condition in which there are large whitish-yellow soft drusen in the macular area and hyperpigmentation or depigmentation of the retinal pigment epithelium associated with the drusen. Small hard drusen may also be present. It occurs most commonly in individuals over 50 years of age and represents the early stage of age-related macular degeneration. The risk of progression of this condition may be decreased by dietary supplements of vitamin C and E, antioxidants (carotenoids such as lutein and zeaxanthin) and minerals (zinc and cupric acid).
References in periodicals archive ?
Multidisciplinary vision rehabilitation programs, including scotoma awareness and eccentric viewing training, have been shown to be effective in improving reading ability, the performance of activities of daily living, and the quality of life of persons with age-related maculopathy (Scanlan & Cuddeford, 2004).
Criteria for Study Inclusion: For the purposes of this systematic review, the term age-related maculopathy (ARM) was used as an overall term and AMD was used to describe late-stage disease.
Age-related maculopathy (or 'early AMD') is clinically characterised by yellowish-white deposits known as drusen, which may have indistinct or clear boundaries and which may be confluent or discrete (Figure 1).
Which of the following about colour vision in Age-Related Maculopathy is TRUE?
Flicker sensitivity and fundus appearance in pre-exudative age-related maculopathy.
Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy.
Contribution of vision variables to mobility in age-related maculopathy patients.
Basal linear deposit and large drusen are specific for early age-related maculopathy.
Eamonn O'Connell of the Department of Ophthalmology at Waterford Regional Hospital in Ireland notes, "Evidence continues to accumulate that oxidative stress is important in age-related maculopathy [equivalent to age-related macular degeneration] and that appropriate antioxidants of dietary origin may protect against this condition.
Macular pigment (MP) is composed of the two dietary carotenoids lutein (L) and zeaxanthin (Z), and is believed to protect against age-related maculopathy (ARM).